Abstract
Tumors frequently affect the skeleton and alter the function of normal bone cells. In most patients, they increase the activity and probably the formation of bone-resorbing osteoclasts. The result is a destructive or osteolytic bone lesion. Occasionally they lead to an increase in activation of osteoblasts or bone-forming cells. In a relatively small number of patients, this increase in osteoblastic activity is profound and the result is an area of newly formed bone around the tumor cell deposit which can be detected radiologically and is referred to as an osteoblastic or sclerotic metastasis. In this chapter, we plan to review what is known of the mechanisms responsible for development of osteolytic and osteoblastic bone lesions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Akatsu T, Takahashi N, Debari K, Morita I, Murota S, Nagata N, Takatani O, Suda T (1989) Prostaglandins promote osteoclast like cell formation by a mechanism involving cyclic adenosine 3’,5’-monophosphate in mouse bone marrow cell cultures. J Bone Miner Res 4:29-35
Ali IU, Lidereau R, Theillet C, Callahan R (1987) Reduction to homozygosity of genes on chromosome 11 in human breast neoplasia. Science 238:185-188
Allan EH, Gough NH, Gelehrter TD, Zeheb R, Martin TJ (1990) Transforming growth factor ß and leukemia inhibitory factor increase mRNA and protein for plasminogen activator inhibitor-1 in osteoblasts. Excerpt a Med Int Congr Ser 886:285-290
Arguello F, Baggs RB, Frantz CN (1988) A murine model of experimental metastasis to bone and bone marrow. Cancer Res 48:6876-6881
Auerbach R, Iu WC, Pardon E, Gumkowski F, Kaminska G, Kaminski M (1987) Specificity of adhesion between murine tumor cells and capillary endothelium: an in vitro correlate of preferential metastasis in vivo. Cancer Res 47:1492-1496
Baker SJ, Fearon ER, Nigro JM, Hamillon SR, Preisinger AC, Jessup JM, van Tuinen P, Ledbetter DH, Barker DF, Nakamura Y (1989) Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 244:217-221
Barsky SH, Rao CN, Williams JE, Liotta LA (1984) Laminin molecular domains which alter metastasis in a murine model. J Clin Invest 74:843-848
Basset P, Bellocq JP, Wolf C, Stoll I, Hutin P, Limacher JM, Podhajcer OL, Chenard MP, Rio MC, Chambon P (1990) A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 348:699-704
Batson OV (1940) The function of the vertebral veins and their role in the spread of metastases. Ann Surg 112:138-149
Bennett A, McDonald AM, Simpson JS, Stanford IF (1975) Breast cancer, prostag- landins, and bone metastases. Lancet 1:1218-1220
Bennett A, Charber EM, McDonald AM, Simpson JS, Stamford IF, Zebro T (1976) Prostaglandins and breast cancer. Lancet 2:624
Benson RC, Riggs BL, Pickard BM, Arnaud CD (1974) Radioimmunoassay of parathyroid hormone in hypercalcemic patients with malignant disease. Am J Med 56:821-826
Bevilacqua G, Sobel ME, Liotta LA, Steeg PS (1989) Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. Cancer Res 49:5185-5190
Biggs J, Hersperger E, Steeg PS, Liotta LA, Shearn A (1990) A Drosophila gene that is homologous to a mammalian gene associated with tumor metastasis codes for a nucleoside diphosphate kinase. Cell 63:933-940
Blood CH, Sasse J, Brodt P, Zetter BR (1988) Identification of a tumor cell recep- tor for VGVAPG, an elastin-derived chemotactic peptide. J Cell Biol 107:1987–1993
Boyce BF, Aufdemorte TB, Garrett IR, Yates AJP, Mundy GR (1989a) Effects of interleukin-1 on bone turnover in normal mice. Endocrinology 125:1142-1150
Boyce BF, Yates AJP, Mundy GR (1989b) Bolus injections of recombinant human interleukin-1 cause transient hypocalcemia in normal mice. Endocrinology 125:2780-2783
Boyde A, Maconnachie E, Reid SA, Delling G, Mundy GR (1986) Scanning electron microscopy in bone pathology: review of methods. Potential and applications. Scanning Electron Microsc 4:1537-1554
Braude S, Graham A, Mitchell D (1991) Lymphoedema/hypercalcaemia syndrome- mediated by parathyroid-hormone-related protein. Lancet 337:140-141
Brem SS, Folkman J (1975) Inhibition of tumor angiogenesis mediated by cartilage. J Exp Med 141:427-439
Budayr AA, Halloran BP, King JC, Diep D, Nissenson RA, Strewler GJ (1989) High levels of a parathyroid hormone-like protein in milk. Proc Natl Acad Sci 86:7183-7185
Canalis E, Lorenzo J, Burgess WH, Maciag T (1987) Effects of endothelial cell growth factor on bone remodeling in vitro. J Clin Invest 79:52-58
Canalis E, Centrella M, McCarthy T (1988) Effects of basic fibroblast growth factor on bone formation in vitro. J Clin Invest 81:1572-1577
Canalis E, McCarthy T, Centrella M (1989) Growth factors and the regulation of bone remodeling. J Clin Invest 81:277-281
Carr I, Orr FW (1983) Current reviews: invasion and metastasis. Can Med Assoc J 128:1164-1167
Chackal-Roy M, Niemeyer C, Moore M, Zetter BR (1989) Stimulation of human prostatic carcinoma cell growth by factors present in human bone marrow. J Clin Invest 84:43-50
Chambers TJ, Ali NN (1983) Inhibition of osteoclastic motility by prostaglandins 12, El, E2 and 6-oxoEl. J Pathol 139:383-397
Charhon SA, Chapuy MC, Delvin EE, Valentin-Opran A, Edouard CM, Meunier PJ (1983) Histomorphometric analysis of sclerotic bone metastases from prostatic carcinoma with special reference to osteomalacia. Cancer 51:918-924
Chenu C, Pfeilschifter J, Mundy GR, Roodman GD (1988) Transforming growth factor beta inhibits formation of osteoclast-like cells in long-term human marrow cultures. Proc Natl Acad Sci USA 85:5683-5687
Chenu C, Valentin-Opran A, Chavassieux P, Saez S, Meunier PJ, Delmas PD (1990) Insulin like growth factor-1 hormonal regulation by growth hormone and by l,25(OH)2D3 and activity on human osteoblast-like cells in short term cultures. Bone 11:81-86
Coman DR, DeLong RP (1951) The role of the vertebral venous system in the metastasis of cancer to the spinal column; experiments with tumour cell suspension in rats and rabbits. Cancer 4:610-618
Corbett JR, Nicod PH, Huxley RL, Lewis SE, Rude RE, Willerson JT (1983) Left ventricular functional alterations at rest and during submaximal exercise in patients with recent myocardial infarction. Am J Med 74:577-591
Danks JA, Ebeling PR, Hayman J, Chou ST, Moseley JM, Dunlop J, Kemp BE, Martin TJ (1989) Parathyroid hormone-related protein: immunohistochemical localization in cancers and in normal skin. J Bone Miner Res 4:273-278
Derynck R, Roberts AB, Winkler ME, Chen EY, Goeddel DV (1984) Human transforming growth factor-alpha: precursor structure and expression in E. coli. Cell 38:287-297
Derynck R, Goeddel DV, Ullrich A, Gutterman JU, Williams RP, Bringman TS, Berger WH (1987) Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors. Cancer Res 47:707-712
Dodds PR, Caride VJ, Lytton B (1981) The role of vertebral veins in the dissemination of prostatic carcinoma. J Urol 126:753-755
Eilon G, Mundy GR (1978) Direct resorption of bone by human breast cancer cells in vitro. Nature 276:726-728
Eilon G, Raisz LG (1978) Comparison of the effects of stimulators and inhibitors of resorption on the release of lysosomal enzymes and radioactive calcium from fetal bone in organ culture. Endocrinology 103:1969-1975
Eisenstein R, Kuettner KE, Neapolitan C, Soble LW, Sorgente N (1975) The resistance of certain tissues to invasion II cartilage extracts inhibit the growth of fibroblasts and endothelial cells in culture. Am J Pathol 81:337-347
Engel J, Odermatt E, Engel A, Madri JA, Furthmayr H, Rohde H, Timpl R (1981) Shapes, domain organization and flexibility of laminin and fibronectin: two multifunctional proteins of the extracellular matrix. Mol Biol 150:97-120
Fidler IJ (1970) Metastasis: quantitative analysis of distribution and fate of tumor emboli labeled with 125I-5-IODO-7’-deoxyuridine. JNCI 45:773-782
Fidler IJ (1973) The relationship of embolic homogeneity, number, size and viability to the incidence of experimental metastasis. Eur J Cancer 9:223-227
Fidler IJ (1978) Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Res 38:2651-2660
Fidler IJ, Poste G (1985) The cellular heterogeneity of malignant neoplasms: implica- tions for adjuvant chemotherapy. Semin Oncol 12:207-221
Fried RM, Voelkel EF, Rice RH, Levine L, Gaffney EV, Tashjian AH (1989) Two squamous cell carcinomas not associated with humoral hypercalcemia produce a potent bone resorption-stimulating factor which is interleukin-1 alpha. Endo- crinology 125:742-751
Galasko CSB (1986a) Skeletal metastases. Clin Orthop 210:18-30
Galasko CSB (1986b) Skeletal metastases. Butterworth, London
Galasko CSB, Burn JI (1971) Hypercalcemia in patients with advanced mammary cancer. Br Med J 3:573-577
Gallacher SJ, Fraser WD, Patel U, Logue FC, Soukop M, Boyle IT, Ralston SH (1990) Breast cancer-associated hypercalcaemia: a reassessment of renal calcium and phosphate handling. Ann Clin Biochem 27:551-556
Garbisa S, Pozzatti R, Muschel RJ, Safflotti V, Ballin M, Goldfarb RH, Khoury G, Liotta LA (1987) Secretion of type IV collagenolytic protease and metastatic phenotype: induction by transfection with c-Ha-ras but not c-Ha-ras plus AD2- Ela. Cancer Res 47:1523-1528
Garrett IR, Mundy GR (1989) Relationship between interleukin-1 and prostaglandins in resorbing neonatal calvariae. J Bone Miner Res 4:789-794
Gordan GS, Fitzpatrick ME, Lubich WP (1967) Identification of osteolytic sterols in human breast cancer. Trans Assoc Am Physicians 80:183-189
Gorelik E, Foggl M, Feldman M, Segal S (1979) Differences in resistance of metastatic tumor cells and cells from local tumor growth to cytotoxicity of natural killer cells. JNCI 63:1397-1404
Grill V, Ho P, Body JJ, Donohoo G, Ferber I, Johanson N, Orf JW, Lee SC, Kukreja SC, Moseley JM, Martin TJ (1991) Parathyroid hormone-related protein: elevated levels in hypercalcemia of malignancy and in hypercalcemia complicating metastatic breast cancer. J Clin Endocrinol Metab 73:1309-1315
Haddad JG, Cowranz SJ, Avioli LV (1970) Circulating phytosterols in normal females, lactating mothers, and breast cancer patients. J Clin Endocrinol Metab 30:174-180
Hanna MG, Zbar B, Rapp HJ (1972) BCG treatment reduced experimental metastases. JNCI 48:441-455
Harinck HI, Bijvoet OL, Plantingh AS, Body JJ, Elte JW, Sleeboom HP, Wildiers J, Neijt JP (1987) Role of bone and kidney in tumor-induced hypercalcemia and its treatment with bisphosphonate and sodium chloride. Am J Med 82:1133-1142
Hauschka PV, Mavrakos AE, Iafrati MD, Doleman SE, Klagsbrun M (1986) Growth factors in bone matrix. J Biol Chem 261:12665-12674
Heppner G (1984) Tumor heterogeneity. Cancer Res 214:2259-2265
Hilgard P, Gordon-Smith EL (1974) Microangiopathic hemolytic anemia and experimental tumor-cell emboli. Br J Haematol 26:651-659
Hujanen ES, Terranova VP (1985) Migration of tumor cells to organ-derived chemoattractants. Cancer Res 45:3517-3521
Ibbotson KJ, Twardzik DR, D’Souza SM, Hargreaves WR, Todaro GJ, Mundy GR (1985) Stimulation of bone resorption in vitro by synthetic transforming growth factor-alpha. Science 228:1007-1009
Ibbotson KJ, Harrod J, Gowen M, D’Souza S, Smith DD, Mundy GR (1986) Human recombinant transforming growth factor alpha stimulates bone resorption and inhibits formation in vitro. Proc Natl Acad Sci USA 83:2228-2232
Isales C, Carcangiu ML, Stewart AF (1987) Hypercalcemia in breast cancer: reassess- ment of the mechanism. Am J Med 82:1143-1147
Jacobs SC, Lawson R (1980) Mitogenic factors in human prostate extracts. Urology 16:488-491
Juliano RL (1987) Membrane receptors for extracellular matrix macromolecules: relationship to cell adhesion and tumor metastasis. Biochim Biophys Acta 907:261-278
Kalebic T, Williams JE, Talmadge JE, Kao-Shan CS, Kravitz B, Locklear K, Siegal GP, Liotta LA, Sobel ME, Steeg PS (1988) A novel method for selection of invasive tumor cells: derivation and characterization of highly metastatic K1735 melanoma cell lines based on in vitro and in vivo invasive capacity. Clin Exp Metastasis 6:301-318
Khosla S, van Heerden JA, Gharib H, Jackson IT, Danks J, Hayman JA, Martin TJ (1990) Parathyroid hormone-related protein and hypercalcemia secondary to massive mammary hyperplasia. N Engl J Med 322:1157
Kjonniksen I, Nesland JM, Pihl A, Fodstad O (1990) Nude rat model for studying metastasis of human tumor cells to bone and bone marrow. JNCI 82:408-412
Klein DC, Raisz LG (1970) Prostaglandins: stimulation of bone resorption in tissue culture. Endocrinology 86:1436-1440
Knabbe C, Lippman ME, Wakefield LM, Flanders KC, Kasid A, Derynck R, Dickson RB (1987) Evidence that transforming growth factor ß is a hormonally regulated negative growth factor in human breast cancer cells. Cell 48:417-428
Koutsilieris M, Rabbani SA, Bennett HP, Goltzman D (1987) Characteristics of prostate-derived growth factors for cells of the osteoblast phenotype. J Clin Invest 80:941-946
Langer R, Conn H, Vacanti J, Haudenschild C, Folkman J (1980) Control of tumor growth in animals by infusion of angiogenesis inhibitor. Proc Natl Acad Sci USA 77:4331-4335
Lerner UH (1987) Modifications of the mouse calvarial technique improve the responsiveness to stimulators of bone resorption. J Bone Miner Res 2:375-383
Liotta LA (1986) Tumor invasion: role of the extracellular matrix. Cancer Res 46:1-7
Liotta LA, Kohn E (1990) Cancer invasion and metastases. JAMA 263:1123-1126
Liotta LA, Schiffmann E (1988) Tumour motility factors. Cancer Surv 7:631-652
Liotta LA, Steeg PS (1990) Clues to the function of Nm23 and Awd proteins in development, signal transduction, and tumor metastasis provided by studies of Dictyostelium discoideum. JNCI 82:1170-1172
Liotta LA, Kleinerman J, Saidel GM (1974) Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implanta- tion. Cancer Res 34:997-1004
Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz C, Shafie S (1980) Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284:67-68
Liotta LA, Mandler R, Murano G, Katz DA, Gordon RK, Chiang PK, Schiffmann E (1986) Tumor cell autocrine motility factor. Proc Natl Acad Sci USA 83: 3302-3306
Lippman ME, Dickson RB, Bates S, Knabbe C, Huff K, Swain S, McManaway M, Bronzert D, Kasid A, Gelmann EP (1986) Autocrine and paracrine growth regulation of human breast cancer. Breast Cancer Res Treat 7:59-70
Lodwick GS (1964) Reactive response to local injury in bone. Radiol Clin North Am 2:209-219
Magro C, Orr FW, Manishen WJ, Sivananthan K, Mokashi SS (1985) Adhesion, chemotaxis, and aggregation of Walker carcinosarcoma cells in response to products of resorbing bone. JNCI 74:829-838
Marcelli C, Yates AJP, Mundy GR (1990) In vivo effects of human recombinant transforming growth factor beta on bone turnover in normal mice. J Bone Miner Res 5:1087-1096
Marquardt H, Lioubin MN, Ikeda T (1987) Complete amino acid sequence of human transforming growth factor type beta 2. J Biol Chem 262:12127-12130
Massague J (1990) Transforming growth factor alpha. A model for membrane- anchored growth factors. J Biol Chem 265:21393-21396
McCarthy JB, Basara ML, Palm SL, Sas DF, Furcht LT (1985) The role of cell adhesion proteins - laminin and fibronectin - in the movement of malignant and metastatic cells. Cancer Metastasis Rev 4:125-152
McCarthy JB, Skubitz APN, Palm SL, Furcht LT (1988) Metastasis inhibition of different tumor types by purified laminin fragments and a heparin-binding fragment of fibronectin. JNCI 80:108-116
Miller FR (1983) Tumor subpopulation interactions in metastasis. Invasion Metastasis 3:234-242
Mundy GR (1990) Calcium homeostasis: hypercalcemia and hypocalcemia. Dunitz, London
Mundy GR, Martin TJ (1982) The hypercalcemia of malignancy: pathogenesis and management. Metabolism 31:1247-1277
Mundy GR, Poser JW (1983) Chemotactic activity of the gamma-carboxyglutamic acid containing protein in bone. Calcif Tissue Int 35:164-168
Mundy GR, DeMartino S, Rowe DW (1981) Collagen and collagen-derived fragments are chemotactic for tumor cells. J Clin Invest 68:1102-1105
Noda M, Camilliere JJ (1989) In vivo stimulation of bone formation by transforming growth factor beta. Endocrinology 124:2991-2994
Nowak RA, Morrison NE, Goad DL, Gaffney EV, Tashjian AH (1990) Squamous cell carcinomas often produce more than a single bone resorption-stimulating factor: role of interleukin-1 alpha. Endocrinology 127:3061-3069
Nowel PS (1976) The clonal evolution of tumor cell subpopulations. Science 194: 23-38
Nussbaum SR, Gaz RD, Arnold A (1990) Hypercalcemia and ectopic secretion of parathyroid hormone by an ovarian carcinoma with rearrangement of the gene parathyroid hormone. N Engl J Med 323:1324-1328
Orr W, Varani J, Gondek MD, Ward PA, Mundy GR (1979) Chemotactic responses of tumor cells to products of resorbing bone. Science 203:176-179
Orr FW, Varani J, Gondek MD, Ward PA, Mundy GR (1980) Partial characterization of a bone derived chemotactic factor for tumor cells. Am J Pathol 99:43-52
Paget S (1889) The distribution of secondary grôwths in cancer of the breast. Lancet 1:571-573
Percival RC, Yates AJP, Gray RES, Galloway J, Rogers K, Neal FE, Kanis JA (1985) Mechanisms of malignant hypercalcemia in carcinoma of the breast. Br Med J 291:776-779
Perroteau I, Salomon D, DeBortoli M, Kidwell W, Hazarika P, Pardue R, Dedman J, Tam J (1986) Immunological detection and quantitation of alpha transforming growth factors in human breast carcinoma cells. Breast Cancer Res Treat 7:201-210
Pfeilschifter JP, Mundy GR (1987) Modulation of transforming growth factor beta activity in bone cultures by osteotropic hormones. Proc Natl Acad Sci USA 84:2024-2028
Pfeilschifter JP, Seyedin S, Mundy GR (1988) Transforming growth factor ß inhibits bone resorption in fetal rat long bone cultures. J Clin Invest 82:680-685
Pfeilschifter J, Bonewald L, Mundy GR (1990a) Characterization of the latent transforming growth factor ß complex in bone. J Bone Miner Res 5:49-58
Pfeilschifter J, Erdmann J, Schmidt W, Naumann A, Minne HW, Ziegler R (1990b) Differential regulation of plasminogen activator and plasminogen activator inhibitor by osteotropic factors in primary cultures of mature osteoblasts and osteoblast precursors. Endocrinology 126:703-711
Poste G (1986) Pathogenesis of metastatic disease: implications for current therapy and for the development of new therapeutic strategies. Cancer Treat Rep 70:183-199
Poste G, Doll J, Fidler IJ (1981) Interactions between clonal subpopulations affect the stability of the metastatic phenotype in polyclonal populations of the B16 melanoma cells. Proc Natl Acad Sci USA 78:6226-6230
Powell GJ, Southby J, Danks JA, Stillwell RG, Hayman JA, Henderson MA, Bennett RC, Martin TJ (1991) Localization of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites. Cancer Res 51:3059-3061
Powles TJ, Dowsett M, Easty GC, Easty DM, Neville AM (1976) Breast cancer osteolysis, bone metastases, and anti-osteolytic effect of aspirin. Lancet 1:608-610
Powles TJ, Muindi J, Coombes RC (1982) Mechanisms for development of bone metastases and effects of anti-inflammatory drugs. In: Powles TJ, Bockman RS, Honn KV, Ramwell P (eds) Prostaglandins and related lipids, vol 2. Liss, New York, pp 541-553
Rabbani SA, Desjardins J, Bell AW, Banville D, Henkin J, Goltzman D (1990a) An amino-terminal fragment of urokinase isolated from a prostate cancer cell line (PC-3) is mitogenic for osteoblast-like cells. Biochem Biophys Res Commun 173:1058-1064
Rabbani SA, Desjardins J, Bell AW, Banville D, Goltzman D (1990b) Identification of a new osteoblast mitogen from a human prostate cancer cell line, PC-3. J Bone Miner Res 5:549
Reedy AL, Fialkow PJ (1980) Multicellular origin of fibrosarcomas in mice induced by the chemical carcinogen 3-methylcholanthrene. J Exp Med 150:878-886
Rizzoli R, Bonjour JP (1989) High extracellular calcium increases the production of a parathyroid hormone-like activity by cultured Leydig tumor cells associated with humoral hypercalcemia. J Bone Miner Res 4:839-844
Rosengard AM, Krutzsch HC, Shearn A, Biggs JR, Barker E, Margulies IM, King CR, Liotta LA, Steeg PS (1989) Reduced Nm23/Awd protein in tumour meta- stasis and aberrant Drosophila development. Nature 342:177-180
Sabatini M, Yates AJ, Garrett R, Chavez J, Dunn J, Bonewald LF, Mundy GR (1990a) Increased production of tumor necrosis factor by normal immune cells in a model of the humoral hypercalcemia of malignancy. Lab Invest 63:676-681
Sabatini M, Chavez J, Mundy GR, Bonewald LF (1990b) Stimulation of tmor necrosis factor release from monolytic cells by the A375 human melanoma via granulocyte-macrophage colony-stimulating factor. Cancer Res 50:2673-2678
Salomon DS, Kidwell WR, Liu S (1986) Presence of alpha TGF mRNA in human breast cancer cell lines and in human breast carcinomas. Breast Cancer Res Treat 8:106A
Sanchez J, Baker V, Miller DM (1986) Review: basic mechanisms of metastasis. Am J Med Sci 292:376-385
Sato K, Fujii Y, Kasono K, Ozawa M, Imamura H, Kanaji Y, Kurosawa H, Tsushima T, Shizume K (1989) Parathyroid hormone-related protein and inter- leukin-lα synergistically stimulate bone resorption in vitro and increase the serum calcium concentration in mice in vivo. Endocrinology 124:2172-2178
Shevrin D, Kukreja SC, Ghosh L, Lad TE (1988) Development of skeletal metastasis by human prostate cancer in athymic nude mice. Clin Exp Metastasis 6:401-409
Simpson EL, Mundy GR, D’Souza SM, Ibbotson KJ, Bockman R, Jacobs JW (1983) Absence of parathyroid hormone messenger RNA in non-parathyroid tumors associated with hypercalcemia. N Engl J Med 309:325-330
Simpson EL, Harrod J, Eilon G, Jacobs JW, Mundy GR (1985) Identification of a mRNA fraction in human prostatic cancer cells coding for a novel osteoblast stimulating factor. Endocrinology 117:1615-1620
Siris ES, Sherman WH, Baquiran DC, Schlatterer JP, Osserman EF, Canfield RE (1980) Effects of dichloromethylene diphosphonate on skeletal mobilization of multiple myeloma. N Engl J Med 302:310-315
Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235:177-182
Southby J, Kissin MW, Danks JA, Hayman JA, Moseley JM, Henderson MA, Bennett RC, Martin TJ (1990) Immunohistochemical localization of para- thyroid hormone-related protein in human breast cancer. Cancer Res 50:7710–7716
Spyratos F, Maudelonde T, Brouillet JP, Brunet M, Defrenne A, Andrieu C, Hacene K, Desplaces A, Rouesse J, Rochefort H (1989) Cathepsin D: an independent prognostic factor for metastasis of breast cancer. Lancet 2:1115–1118
Stahl KW, Mathe G, Kovacs G (1985) Decrease of metastogenic potential by pregraft treatment of Lewis lung carcinoma cells with proteinase and protein kinase affinity labels. Cancer Res 45:5335-5340
Stashenko P, Dewhirst FE, Rooney ML, Desjardins LA, Heeley JD (1987) Interleukin- 1A is a potent inhibitor of bone formation in vitro. J Bone Miner Res 2:559-565
Steeg PS (1989) Search for metastasis suppressor genes. Invasion Metastasis 9: 351-359
Steeg PS, Bevilacqua G, Kopper L, Thorgeirsson UP, Talmadge JE, Liotta LA, Sobel ME (1988) Evidence for a novel gene associated with low tumor metastatic potential. JNCI 80:200-204
Stern PH, Krieger NS, Nissenson RA, Williams RD, Winkler ME, Derynck R, Strewler GJ (1985) Human transforming growth factor alpha stimulates bone resorption in vitro. J Clin Invest 76:2016-2019
Stewart AF, Horst R, Deftos LJ, Cadman EC, Lang R, Broadus AE (1980) Bio- chemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups. N Engl J Med 303:1377-1383
Stewart AF, Wu T, Goumas D, Burtis WJ, Broadus AE (1987) N-terminal amino acid sequence of two novel tumor-derived adenylate cyclase-stimulating proteins: identification of parathyroid hormone-like and parathyroid hormone-unlike domains. Biochem Biophys Res Commun 146:672-678
Takahashi N, Mundy GR, Roodman GD (1986) Recombinant human interferon gamma inhibits formation of human osteoclast like cells. J Immunol 137: 3544-3549
Tashjian AH, Voelkel EF, Levine L, Goldhaber P (1972) Evidence that the bone resorption-stimulating factor produced by mouse fibrosarcoma cells is prostag- landin E2: a new model for the hypercalcemia of cancer. J Exp Med 136:1329-1343
Tashjian AH, Voelkel EF, Lazzaro M, Singer FR, Roberts AB, Derynck R, Winkler ME, Levine L (1985) Alpha and beta transforming growth factors stimulate prostaglandin production and bone resorption in cultured mouse calvaria. Proc Natl Acad Sci USA 82:4535-4538
Thiede MA, Rodan GA (1988) Expression of a calcium-mobilizing parathyroid hormone-like peptide in lactating mammary tissue. Science 242:278-280
Thompson SL (1974) The colony forming efficiency of single cells and cell aggregates from a spontaneous mouse mammary tumor using the lung colony assay. Br J Cancer 30:332-336
Tofe AJ, Francis MD, Harvey WJ (1975) Correlation of neoplasms with incidence and localization of skeletal metastases. An analysis of 1355 diphosphonate bone scans. J Nucl Med 16:986-989
Tsuchida T, Fujiwara H, Tsuji Y, Hamaoka T (1981) Inhibitory effect of Propioni-bacterium acnes-activated macrophages on tumor métastasés induced by tumor- specific immunosuppression. Gan 72:205-212
Tuttle KR, Kunau RT, Loveridge N, Mundy GR (1991) Altered renal calcium handling in the hypercalcemia of malignancy. J Am Soc Nephrol 2:191-199
Vaes G (1968) On the mechanisms of bone resorption. The action of parathyroid hormone on the excretion and synthesis of lysosomal enzymes and on the extracellular release of acid by bone cells. J Cell Biol 39:676-697
Valentin A, Eilon G, Saez S, Mundy GR (1985) Estrogens and anti-estrogens stimulate release of bone resorbing activity by cultured human breast cancer cells. J Clin Invest 75:726-731
Van Breukelen FJM, Bijvoet OLM, van Oosterom AT (1979) Inhibition of osteolytic bone lesions by (3-amino-1-hydroxypropylidene)-1. 1. bisphosphonate (A.P.D.). Lancet 1:803-805
Van den Brenk HAS, Burch WM, Kelley H, Orton C (1975) Venous diversion trapping and growth of blood-borne cancer cells en route to the lungs. Br J Cancer 31:46-61
Vignon F, Capony F, Chambon M, Freiss G, Garcia M, Rochefort H (1986) Autocrine growth stimulation of the MCF-7 breast cancer cells by the estrogen-regulated 52K protein. Endocrinology 118:1537-1545
Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL (1988) Genetic alterations during colorectal tumor development. N Engl J Med 319:525-532
Warren BA, Vales O (1972) The adhesion of thromboplastic tumor emboli to vessel walls in vivo. Br J Exp Pathol 53:301-313
Weiss L (1985) Metastatic inefficiency in principles of metastasis. In: Weiss L, Gilbert H (eds) Liver metastasis. Academic Press, p 148
Weiss L, Glanes D (1974) Waited, the influence of host immunity on the arrest of circulating cancer cells and its modification by neuraminidase. Int J Cancer 13:850-862
Weiss L, Orr FW, Honn KV (1989) Interactions between cancer cells and the micro vasculature: a rate-regulator for metastasis. Clin Exp Metastasis 7:127-167
Westley BR, May FEB (1987) Oestrogen regulates cathepsin D mRNA levels in oestrogen responsive human breast cancer cells. Nucleic Acids Res 15:3771–3786
Wewer UM, Taraboletti G, Sobel ME, Albrechtsen R, Liotta LA (1987) Laminin receptor: role in tumor cell migration. Cancer Res 47:5691-5698
Winterbauer RH, Elfenbein IB, Ball WC (1968) Incidence and clinical significance of tumor embolization to the lungs. Am J Med 45:271-290
Wo Z, Bonewald L, Oreffo ROC, Chirgwin JW, Capony F, Rochefort H, Mundy GR (1990) The potential role of procathepsin D secreted by breast cancer cells in bone resorption. In: Cohn DV, Glorieux FH, Martin TJ (eds) Calcium regulation and bone metabolism. Basic and clinical aspects, vol 10. Elsevier, Amsterdam, pp 304-310
Yates AJP, Oreffo ROC, Mayor K, Mundy GR (1991) Inhibition of bone resorption by inorganic phosphate is mediated both by reduced osteoclast formation and by impaired activity of mature osteoclasts. J Bone Miner Res 6:473-478
Yoneda T, Alsina MM, Chavez JB, Bonewald L, Nishimura R, Mundy GR (1991) Evidence that splenic cytokines play a pathogenetic role in the paraneoplastic syndromes of cachexia, hypercalcemia and leukocytosis in a human tumor in nude mice. J Clin Invest 87:977-985
Yoshimoto K, Yamasaki R, Sakai H, Tezuka U, Takahashi M, Iizuka M, Sekiya T, Saito S (1989) Ectopic production of parathyroid hormone by small cell lung cancer in a patient with hypercalcemia. J Clin Endocrinol Metab 68:976-981
Yusa T, Blood CH, Zetter BR (1989) Tumor cell interactions with elastin: implica- tions for pulmonary metastasis. Am Rev Respir Dis 140:1458-1462
Zetter BR (1990) The cellular basis of site-specific tumor metastasis. N Engl J Med 322:605-612
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Mundy, G.R., Martin, T.J. (1993). Pathophysiology of Skeletal Complications of Cancer. In: Physiology and Pharmacology of Bone. Handbook of Experimental Pharmacology, vol 107. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77991-6_18
Download citation
DOI: https://doi.org/10.1007/978-3-642-77991-6_18
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-77993-0
Online ISBN: 978-3-642-77991-6
eBook Packages: Springer Book Archive